Abstract
The report covers a forecast and an analysis of the next generation sequencing market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2026 based on revenue (USD Million). The study includes drivers and restraints of the next generation sequencing market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the next generation sequencing market on a global level.
In order to give the users of this report a comprehensive view of the next generation sequencing market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, product, and regional expansion of major participants involved in the market.
The study provides a decisive view of the next generation sequencing market on the basis of products and services, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2026. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc.
Some major players in the global next generation sequencing market are F. Hoffmann-La Roche, ABM, Agilent Technologies, BD, Oxford Nanopore Technologies, LGC Limited, BGI, Eurofins Genomics, Illumina, Roche Sequencing, DNASTAR, Macrogen, Pacific Biosciences of California, QIAGEN, and Thermo Fischer Scientific.
This report segments the global next generation sequencing market into:
Global Next Generation Sequencing Market: Products and Services Analysis
Products by Technology
Sequencing by Synthesis
Sequencing by Ligation
Ion Semiconductor Sequencing
Nanopore Sequencing
Sequencing Services by Type
Genomics
Whole Genome Sequencing
Exome Sequencing
De Novo Sequencing
Targeted Sequencing
Transcriptomics
Total RNA and mRNA Sequencing
Targeted RNA Sequencing
Small RNA and Noncoding RNA Sequencing
Epigenomics
Methylation Sequencing
ChIP Sequencing
Ribosome Profiling
Others
Global Next Generation Sequencing Market: Application Analysis
Bioinformatics
Diagnostics
Cancer
Neonatal Screening
Infectious Disease
Reproductive Health
Genetic Testing
Monogenic Disorders
Others
Agriculture and Animal Research
Drug Discovery
Genetic Research
Others
Global Next Generation Sequencing Market: End-User Analysis
Research Institutes
Pharmaceuticals
Biotechnology Companies
Hospitals
Academic Institutes
Global Next Generation Sequencing Market: Regional Analysis
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa